Cargando…

Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer

Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating hormone (rhTSH) for radioiodine remnant ablation. On this basis, rhTSH was approved in Europe for the radioiodine ablation of low-risk differentiated thyroid cancer (DTC) during thyroid hormone therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biondi, Bernadette, Pulcrano, Melania, Pagano, Loredana, Lombardi, Gaetano
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726080/ https://www.ncbi.nlm.nih.gov/pubmed/19707391

Ejemplares similares

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
por: Pitoia, Fabián, et al.
Publicado: (2012)

The Association of Thyrotropin and Autoimmune Thyroid Disease in Developing Papillary Thyroid Cancer
por: Lee, I-Shuan, et al.
Publicado: (2017)

Diagnosis and Treatment of Acute Pleural Effusion following Radioiodine Remnant Ablation Post Lobectomy for Thyroid Cancer
por: Qiu, Xian, et al.
Publicado: (2022)

Efficacy and Affecting Factors of (131)I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
por: Wang, Chen, et al.
Publicado: (2018)

Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients
por: Papaleontiou, Maria, et al.
Publicado: (2016)

Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer
por: Zheng, Jiaojiao, et al.
Publicado: (2016)

I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
por: Lin, Rong, et al.
Publicado: (2015)

Scintigraphic evaluation of salivary gland function in thyroid cancer patients after radioiodine remnant ablation
por: Krčálová, Eva, et al.
Publicado: (2020)

Circulating thyrotropin is upregulated by estradiol
por: Benvenga, Salvatore, et al.
Publicado: (2018)

Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer
por: Ha, Seunggyun, et al.
Publicado: (2015)

The Relationship between Thyrotropin Serum Concentrations and Thyroid Carcinoma
por: Zhang, Xueqi, et al.
Publicado: (2023)

Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational Study
por: van der Horst-Schrivers, Anouk N. A., et al.
Publicado: (2015)

SAT525 Long-Term Outcomes in Stage I Thyroid Cancer Without Radioiodine Remnant Ablation
por: Mubeen, Faiza, et al.
Publicado: (2023)

Dissociation of thyrotropin receptor function and thyrotropin dependency in rat thyroid tumour cell lines derived from FRTL-5.
por: van der Kallen, C. J., et al.
Publicado: (1996)

Hashimoto’s Thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer
por: Ye, Zhi-qiang, et al.
Publicado: (2013)

Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment
por: Bal, Chandrasekhar, et al.
Publicado: (2015)

Factors modulating the secretion of thyrotropin and other hormones of the thyroid axis.
por: Hedge, G A, et al.
Publicado: (1981)

The Thyroid in Mind: Cognitive Function and Low Thyrotropin in Older People
por: Gan, Earn H., et al.
Publicado: (2012)

Painless Thyroiditis with Thyrotropin Receptor-blocking and Receptor-stimulating Autoantibodies
por: Kamijo, Keiichi
Publicado: (2019)

Cardiac Effects of Thyrotropin Oversuppression with Levothyroxine in Young Women with Differentiated Thyroid Cancer
por: Hong, Kyung-Soon, et al.
Publicado: (2016)

The risk between thyrotropin suppression and bone mineral density in differentiated thyroid cancer
por: Zou, Yang, et al.
Publicado: (2022)

Can Thyrotropin, Tri-Iodothyronine, and Thyroxine Hormones be Predictors of Cancer in Thyroid Lesions?
por: Khider, Mohamed O, et al.
Publicado: (2022)

Assessment of Different Radioiodine Doses for Post-ablation Therapy of Thyroid Remnants: A Systematic Review
por: Ansari, Mojtaba, et al.
Publicado: (2022)

Regional Variation across Canadian Centers in Radioiodine Administration for Thyroid Remnant Ablation in Well-Differentiated Thyroid Cancer Diagnosed in 2000–2010
por: Rachinsky, I., et al.
Publicado: (2016)

Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer
por: Lv, Rong-Bin, et al.
Publicado: (2017)

Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer
por: Ha, Jeonghoon, et al.
Publicado: (2017)

Thyrotropin serum levels and coexistence with Hashimoto’s thyroiditis as predictors of malignancy in children with thyroid nodules
por: Zirilli, Giuseppina, et al.
Publicado: (2019)

Thyroid hormone receptor β sumoylation is required for thyrotropin regulation and thyroid hormone production
por: Ke, Sujie, et al.
Publicado: (2021)

Radioiodine Remnant Ablation: A Critical Review
por: Bal, Chandra Sekhar, et al.
Publicado: (2015)

A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol
por: Lee, Eun Kyung, et al.
Publicado: (2020)

Graves’ disease diagnosed in remnant thyroid after lobectomy for thyroid cancer
por: Jin, Meihua, et al.
Publicado: (2022)

An overall and dose-response meta-analysis for thyrotropin and thyroid cancer risk by histological type
por: Hu, Na, et al.
Publicado: (2016)

Optimal Thyrotropin Suppression Therapy in Low-Risk Thyroid Cancer Patients after Lobectomy
por: Lee, Yu-Mi, et al.
Publicado: (2019)

Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels
por: Kim, Hosu, et al.
Publicado: (2021)

Simultaneous Coexistence of Thyrotropin-Prolactin-Secreting Adenoma and Papillary Thyroid Carcinoma
por: Safi, Somaya, et al.
Publicado: (2021)

Sensitivity of three thyrotropin receptor antibody assays in thyroid-associated orbitopathy
por: Sarić-Matutinović, Marija, et al.
Publicado: (2022)

The Effect of Thyrotropin-Releasing Hormone and Antithyroid Drugs on Fetal Thyroid Function
por: Vrachnis, Nikolaos, et al.
Publicado: (2021)

Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
por: Makarewicz, Jacek, et al.
Publicado: (2010)

I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence
por: Shengguang, Yan, et al.
Publicado: (2016)

Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome?
por: Hay, Ian D, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ddjompjt1hskir7glp50ienses